DIRECCIÓN
LIVE STREAMING Ver mapaCoordinadoras Científicas
- Dra. Enriqueta Felip
Hospital Universitari Vall d’Hebron. Barcelona. - Dra. Noemí Reguart
Hospital Clinic. Barcelona.
Programa
16:00h – 16:05h Welcome
-Dr. Enriqueta Felip, Hospital Universitari Vall d’Hebron, Barcelona
-Dr. Noemi Reguart, Hospital Clínic, Barcelona
16:05h – 17:30h SESSION 1: EVOLUTION OF THERAPY FOR EARLY-STAGE NSCLC
Chairpersons:
-Dr. Luis Paz-Ares, Hospital Universitario 12 de Octubre, Madrid
-Dr. Dolores Isla, Hospital Clínico Universitario Lozano Blesa, Zaragoza
16:05h – 16:25h MASTER LECTURE: Progress and prospects of perioperative IO in early-stage NSCLC
Prof. Sanjay Popat, The Royal Marsden Hospital, London, United Kingdom
16:25h – 16: 40h Weighing options for “potentially resectable”. T4 & N2 disease
Dr. Mariano Provencio, Hospital Puerta de Hierro, Madrid
16:40h – 16:55h Biomarkers & surrogates to personalize IO strategies in early-stage NSCLC
Dr. Ernest Nadal, Institut Català d’Oncologia, L’Hospitalet de Llobregat, Barcelona
16:55h – 17:10h New advances with targeted therapies in early-stage
Dr. Margarita Majem, Hospital de la Santa Creu i Sant Pau, Barcelona
17:10h – 17:30h Discussion
SESSION 2: SECOND-LINE NSCLC, OPPORTUNITIES & CHALLENGES
Chairpersons:
-Dr. Enric Carcereny, Institut Català d’Oncologia – Hospital Universitari Germans Trias i Pujol, Badalona
-Dr. Silvia Catot, Hospital Althaia Xarxa Assistencial Universitària de Manresa, Barcelona
17:40h – 17:55h Understanding the mechanisms of IO-resistance
Dr. Ignacio Gil-Bazo, Instituto Valenciano de Oncologia, Valencia
17:55h – 18:10h Novel IO strategies and combinations to overcome resistance
Dr. Rosario García Campelo, Complexo Hospitalario Universitario de A Coruña
18:10h – 18:25h Updates on results with Antibody Drug Conjugates (ADCs)
Dr. Pilar Garrido, Hospital Universitario Ramón y Cajal, Madrid
18:25h – 18:40h Future directions for ADCs (biomarkers, bispecifics, new drug conjugates, sequence and resistance)
Dr. Edurne Arriola, Hospital del Mar, Barcelona
18:40h – 18:55h Targeted Therapies for KRAS + NSCLC
Dr. Jordi Remon, Gustave Roussy, Paris, France
18:55h – 19:15h Discussion
19:15h – 19:20h Closing Remarks
– Dr. Enriqueta Felip, Hospital Universitari Vall d’Hebron, Barcelona
– Dr. Noemi Reguart, Hospital Clínic, Barcelona